Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NEW FUSED-HETEROCYCLIC COMPOUND AS CDK INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/227125
Kind Code:
A1
Abstract:
Disclosed in the present invention is a new fused-heterocyclic compound having target inhibitory activity for CDKs, and specifically disclosed is a compound having a structure as represented by formula (I) as a target inhibitor for CDKs or a pharmaceutically acceptable salt, a solvate, a hydrate, an isotope substitute or an isomer thereof.

Inventors:
ZHANG LONG (CN)
NIU ZHANGMING (CN)
Application Number:
PCT/CN2023/096666
Publication Date:
November 30, 2023
Filing Date:
May 26, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MINDRANK AI LTD (CN)
International Classes:
C07D401/14; A61K31/395; A61P35/00; A61P37/06; C07D403/14; C07D487/02
Domestic Patent References:
WO2015154022A12015-10-08
WO2016105528A22016-06-30
WO2016210291A12016-12-29
WO2016210296A12016-12-29
WO2019157959A12019-08-22
Foreign References:
CN107530329A2018-01-02
CN112367991A2021-02-12
CN107427521A2017-12-01
CN106458990A2017-02-22
CN105849099A2016-08-10
CN113880772A2022-01-04
CN114133394A2022-03-04
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: